Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.5430
-0.0503 (-8.48%)
At close: Jul 29, 2026, 4:00 PM EDT
0.5497
+0.0067 (1.23%)
After-hours: Jul 29, 2026, 6:43 PM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $159.97 million as of July 29, 2026. Its market cap has increased by 59.27% in one year.
Market Cap
159.97M
Enterprise Value
-10.55M
1-Year Change
59.27%
Ranking
Category
Stock Price
$0.54
ChartMarket Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $159.97M, a decrease of -92.94%. That is a compound annual growth rate of -41.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 159.97M | -76.63% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | 2.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 181.23M |
| Pyxis Oncology | 181.20M |
| Voyager Therapeutics | 180.66M |
| Immunic | 179.80M |
| Jyong Biotech | 176.68M |
| AN2 Therapeutics | 174.32M |
| Humacyte | 173.75M |
| Innate Pharma | 173.08M |